1-(5-Methylbenzo[d]oxazol-2-yl)guanidine

Catalog No.: 
ACGMWJ834
CAS No.: 
332898-09-6
Molecular Formula: 
C9H10N4O
Molecular Weight: 
190.21
1-(5-Methylbenzo[d]oxazol-2-yl)guanidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$98.00InquiryInquiry
100mg95%$139.00InquiryInquiry
250mg95%$190.00InquiryInquiry
1g95%$364.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(5-Methylbenzo[d]oxazol-2-yl)guanidine
IUPAC Name1-(5-methylbenzo[d]oxazol-2-yl)guanidine
MDL No.MFCD01796091
Molecular FormulaC9H10N4O
Molecular Weight190.21
SMILESNC(NC1=NC2=CC(C)=CC=C2O1)=N
InChI KeyGNJXROFFRNCGLI-UHFFFAOYSA-N
SynonymASISCHEM T03044;ART-CHEM-BB B016036;N-(5-METHYL-BENZOOXAZOL-2-YL)-GUANIDINE;N-(5-METHYL-1,3-BENZOXAZOL-2-YL)GUANIDINE;TOSLAB-BB TOS-BB-1291;TIMTEC-BB SBB009389;AKOS BBS-00005692;AKOS B016036
CAS No.332898-09-6

Synthetic Route by SureRoute

1. ACGMWJ834 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYKMH067 route compound structure diagram
    ACYKMH06722876-15-9In Stock
  2. Plus
  3. ACABXR840 route compound structure diagram
    ACABXR84050979-18-5In Stock
  4. Then
  5. ACGMWJ834 route product structure diagram
    ACGMWJ834332898-09-6
Inquiry

2. ACGMWJ834 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACABXR840 route compound structure diagram
    ACABXR84050979-18-5In Stock
  4. Then
  5. ACGMWJ834 route product structure diagram
    ACGMWJ834332898-09-6
Inquiry

3. ACGMWJ834 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACABXR840 route compound structure diagram
    ACABXR84050979-18-5In Stock
  4. Then
  5. ACGMWJ834 route product structure diagram
    ACGMWJ834332898-09-6
Inquiry

Comments (0)